dronabinol has been researched along with Carcinoma, Basal Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dajani, EZ; Dajani, NE; Dayton, MT; Larsen, KR; Mir, GN; Neeleman, SD; Shahwan, TG; Taylor, J; Taylor, MS | 1 |
1 other study(ies) available for dronabinol and Carcinoma, Basal Cell
Article | Year |
---|---|
1',1'-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties.
Topics: Administration, Oral; Analgesia; Analgesics; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cannabinoids; Carcinoma, Basal Cell; Dimethyl Sulfoxide; Dronabinol; Drug Interactions; Indomethacin; Injections, Intraperitoneal; Male; Mice; Pain Measurement; Rats; Rats, Wistar; Stomach Ulcer | 1999 |